Bronchopulmonary Aspergillosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2010-01-07
Clinical Trial Update: Voriconazole For Chronic Bronchopulmonary Aspergillosis [Phase 2, Phase 3]
Pfizer-sponsored Phase 2/3 trials evaluated voriconazole for chronic bronchopulmonary aspergillosis. The results were posted in January 2010…